Navigation Links
Role of pro-urokinase in neuronal apoptosis and revascularization after ACI
Date:5/12/2014

Among the drugs used for acute ischemic stroke, recombinant tissue plasminogen activator is widely accepted internationally. In China, urokinase has been widely used for thrombolysis after acute ischemic stroke. Pro-urokinase is the precursor of urokinase. Compared with urokinase, pro-urokinase has greater ability to dissolve thrombus and is safer to use. However, most countries do not recognize urokinase for thrombolytic treatment after acute ischemic stroke, which has not been approved for clinical use. Dr. Wenli Hu and team from Beijing Chao-Yang Hospital, Capital Medical University in China compared the thrombolytic effects of pro-urokinase, recombinant tissue plasminogen activator, and urokinase in a dog model of acute cerebral embolism. They found that jematoxylin and eosin staining showed no hematoma in the infarcted area after thrombolysis with any of the three therapies, and neuronal apoptosis after cerebral infarction was also not attenuated. The results of angiography showed that recanalization after thromboembolism was similar after thrombolysis with pro-urokinase and recombinant tissue plasminogen activator, and that both these drugs were more effective than urokinase. The relevant article was published in the Neural Regeneration Research (Vol. 9, No. 5, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Pretreatment with SSTF prevents hippocampal neuronal apoptosis due to cerebral infarction
2. Impaired cell division leads to neuronal disorder
3. Activating P300 protein contributes to repair of hippocampal neuronal DNA injuries
4. How the Parkin enzyme inhibits neuronal cell death
5. Hippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia
6. Overexpression of cytoglobin gene increases neuronal hypoxic tolerance
7. Haste and waste on neuronal pathways
8. Different neuronal groups govern right-left alternation when walking
9. Parkinsons disease: Parkin protects from neuronal cell death
10. Neuronal activity induces tau release from healthy neurons
11. Cilia guide neuronal migration in developing brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Role of pro-urokinase in neuronal apoptosis and revascularization after ACI
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/14/2015)... , May 14, 2015 Research and Markets ... of the "Fingerprint Sensors Market in Smart Mobile ... This report believes that 2014 was a watershed year ... Apple,s introduction of ,Apple Pay,. Apple gave fingerprint sensors ... mobile payment service. Fingerprint sensors are a must-have feature ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... up to return to Russia to oversee preparations for the ... on 16 March 2009. This follows implementation of the corrective ... the launch of GOCE by Eurockot Launch Services last October. ... the Plesetsk Cosmodrome in northern Russia to arrange logistical matters ...
... pregnant female and a male of the same species--reveal how ... whales made the transition from land to sea. The ... and studied at the University of Michigan, are described in ... PLoS . U-M paleontologist Philip Gingerich, who led the ...
... Stem Cell Initiative, a partnership of academia, industry and public ... educate the public about its impact, will meet Feb. 10 ... The free daylong symposium is open to the public and ... of stem cells in areas such as stroke, heart attack ...
Cached Biology News:March launch planned for ESA's gravity mission 2Early whales gave birth on land, fossil find reveals 2Georgia Stem Cell Initiative meets on MCG campus Feb. 10 2Georgia Stem Cell Initiative meets on MCG campus Feb. 10 3
(Date:5/21/2015)... SURPRISE, ARIZ. (PRWEB) May 21, 2015 ... E. Webb Medical Center (BDWMC), Sun Health Foundation funded ... medical center’s new inpatient pharmacy with the most up-to-date ... to open June 2. The pharmacy's 45 staff members ... much larger 4,895-square-foot space in the coming days. ...
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 The global ... of 22.3% during the forecast period of 2015 to ... increasingly being used in drug discovery and development process ... market growth. In addition to this,heavy investments by key ... applications are also propelling market growth. Browse 113 market ...
(Date:5/20/2015)... 20, 2015  Cypher Genomics, Inc., a leading ... Celgene Corporation to apply Cypher,s Coral TM ... with patient response to innovative medicines. The information ... accelerate patient access to the right medicine at ... and development and potentially inform new companion diagnostics.  ...
Breaking Biology Technology:Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company focused ... announced that it has completed the dose escalation stage of an ... heart failure.  Nile had previously announced that the study, NIL-CDNP-CT005, was ... Phase II studies. , , ...
... May 7, 2010 HOYA Corporation today,announced financial results for the fourth ... 104.8 billion yen for the quarter,representing an increase of 26.4% from ... recovery in orders in the main business fields,such as Electro-Optics, as well as ... , ...
... the Swedish medical university Karolinska Institutet shows that the ... cholesterol and thereby cause an inflammation that leads to ... receptors, the researchers have managed to inhibit the development ... in the distinguished periodical Journal of Experimental Medicine ...
Cached Biology Technology:Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 2Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study 3Hoya Announces Fourth Quarter and Full-Year Financial Results 2Hoya Announces Fourth Quarter and Full-Year Financial Results 3New atherosclerosis vaccine gives promising results 2
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
... SYBR Green I nucleic acid gel ... gel stain that has bright fluorescence when bound ... it ideal for detecting dsDNA in gels using ... I nucleic acid stain has also found uses ...
Synonym: modified Grace's Insect medium...
... ingredient in Molecular Probes. SlowFadeAntifade Kits ... act as a free radical scavenger ... original SlowFade formulation (S-2828) was designed ... fluorescein to almost zero (Figure 1); ...
Biology Products: